BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28951454)

  • 1. Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.
    Sivakumar S; Lucas FAS; McDowell TL; Lang W; Xu L; Fujimoto J; Zhang J; Futreal PA; Fukuoka J; Yatabe Y; Dubinett SM; Spira AE; Fowler J; Hawk ET; Wistuba II; Scheet P; Kadara H
    Cancer Res; 2017 Nov; 77(22):6119-6130. PubMed ID: 28951454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
    Sivakumar S; San Lucas FA; Jakubek YA; McDowell TL; Lang W; Kallsen N; Peyton S; Davies GE; Fukuoka J; Yatabe Y; Zhang J; Futreal PA; Fowler J; Fujimoto J; Ehli EA; Hawk ET; Wistuba II; Kadara H; Scheet P
    EBioMedicine; 2019 Apr; 42():296-303. PubMed ID: 30905849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
    Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
    J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.
    Izumchenko E; Chang X; Brait M; Fertig E; Kagohara LT; Bedi A; Marchionni L; Agrawal N; Ravi R; Jones S; Hoque MO; Westra WH; Sidransky D
    Nat Commun; 2015 Sep; 6():8258. PubMed ID: 26374070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
    Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.
    Kohno T; Kunitoh H; Suzuki K; Yamamoto S; Kuchiba A; Matsuno Y; Yanagitani N; Yokota J
    Carcinogenesis; 2008 May; 29(5):957-63. PubMed ID: 18299280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
    Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
    Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
    Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
    Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
    Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Expression Profiles of Multiple Synchronous Lesions in Lung Adenocarcinoma.
    Lim J; Han YB; Park SY; Ahn S; Kim H; Kwon HJ; Lee CT; Cho S; Chung JH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
    Licchesi JD; Westra WH; Hooker CM; Herman JG
    Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchioloalveolar neoplasia.
    Kitamura H; Okudela K
    Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
    Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
    Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.